Home › Glioma › Texas › Houston

Pag-aaral pangklinika para sa Glioma sa Houston, TX

Isang pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Houston

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05417594

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Nagre-recruitPhase 1/2

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
UT MD Anderson Cancer Center, Houston

12 Months – 21 Years · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05099003

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Nagre-recruitPhase 1

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT03896568

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Nagre-recruitPhase 1/2

Baylor College of Medicine, Houston

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06838676

MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas

Nagre-recruit

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04373720

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

Nagre-recruitObservasyonal na pag-aaral

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04771806

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Nagre-recruitPhase 1

The University of Texas M. D. Anderson Cancer Center, Houston

36 Months · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07076498

Targeted Pediatric High-Grade Glioma Therapy

Nagre-recruitObservasyonal na pag-aaral

Texas Children's Hospital, Houston

12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

36 Months – 22 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03911388

Study of Olutasidenib and Temozolomide in HGG

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Nagre-recruitPhase 3

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

Edad 3 hanggang 39 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05096481

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Nagre-recruitObservasyonal na pag-aaral

M D Anderson Cancer Center, Houston

Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT01772771

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Nagre-recruitPhase 1

Excel Diagnostics & Nuclear Oncology Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07733674

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Nagre-recruitPhase 1

Texas Children's Hospital, Houston

12 Months – 25 Years · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT04099797

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2

University of Texas MD Anderson Cancer Center, Houston

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo

Texas Children's Hospital, Houston

Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06333899

Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas

Nagre-recruitMaagang Phase 1

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT05804227

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nagre-recruitPhase 2

Texas Children's Hospital, Houston

12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06326411

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Nagre-recruitPhase 1/2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Nagre-recruitMaagang Phase 1

Texas Children's Hospital, Houston

Hanggang edad 21 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT04655404

Pag-aaral para sa Glioma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.